Connecting Clinical and Genetic Heterogeneity in ADHD
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Demontis D, Walters G, Athanasiadis G, Walters R, Therrien K, Nielsen T
. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023; 55(2):198-208.
PMC: 10914347.
DOI: 10.1038/s41588-022-01285-8.
View
2.
Demontis D, Walters R, Martin J, Mattheisen M, Als T, Agerbo E
. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2018; 51(1):63-75.
PMC: 6481311.
DOI: 10.1038/s41588-018-0269-7.
View
3.
Grotzinger A, Mallard T, Akingbuwa W, Ip H, Adams M, Lewis C
. Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. Nat Genet. 2022; 54(5):548-559.
PMC: 9117465.
DOI: 10.1038/s41588-022-01057-4.
View
4.
LaBianca S, Brikell I, Helenius D, Loughnan R, Mefford J, Palmer C
. Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorder. Nat Genet. 2023; 56(2):234-244.
PMC: 11439085.
DOI: 10.1038/s41588-023-01593-7.
View
5.
Mattheisen M, Grove J, Als T, Martin J, Voloudakis G, Meier S
. Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups. Nat Genet. 2022; 54(10):1470-1478.
PMC: 10848300.
DOI: 10.1038/s41588-022-01171-3.
View